The Bilateral Ovariectomy in a Female Animal Exacerbates the Pathogenesis of an Intracranial Aneurysm.

endothelial cell estrogen female intracranial aneurysm macrophage subarachnoid hemorrhage

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
31 May 2020
Historique:
received: 24 04 2020
revised: 23 05 2020
accepted: 28 05 2020
entrez: 4 6 2020
pubmed: 4 6 2020
medline: 4 6 2020
Statut: epublish

Résumé

Considering the poor outcome of subarachnoid hemorrhage (SAH) due to the rupture of intracranial aneurysms (IA), mechanisms underlying the pathogenesis of IAs, especially the rupture of lesions, should be clarified. In the present study, a rat model of IAs in which induced lesions spontaneously ruptured resulting in SAH was used. In this model, the combination of the female sex and the bilateral ovariectomy increased the incidence of SAH, similar to epidemiological evidence in human cases. Importantly, unruptured IA lesions induced in female animals with bilateral ovariectomy were histopathologically similar to ruptured ones in the presence of vasa vasorum and the accumulation of abundant inflammatory cells, suggesting the exacerbation of the disease. The post-stenotic dilatation of the carotid artery was disturbed by the bilateral ovariectomy in female rats, which was restored by hormone replacement therapy. The in vivo study thus suggested the protective effect of estrogen from the ovary on endothelial cells loaded by wall shear stress. -estradiol or dihydrotestosterone also suppressed the lipopolysaccharide-induced expression of pro-inflammatory genes in cultured macrophages and neutrophils. The results of the present study have thus provided new insights about the process regulating the progression of the disease.

Identifiants

pubmed: 32486339
pii: brainsci10060335
doi: 10.3390/brainsci10060335
pmc: PMC7349062
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Core Research for Evolutional Science and Technology (CREST) on Mechanobiology from the Japan Agency for Medical Research and Development (AMED)
ID : JP18gm0810006 and JP19gm0810006

Déclaration de conflit d'intérêts

M.K. was supported by CREST on Mechanobiology from AMED, grant number JP18gm0810006 and JP19gm0810006, until 31 March, 2020. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Références

Acta Neuropathol Commun. 2014 Mar 31;2:34
pubmed: 24685329
J Neurosurg. 2005 Dec;103(6):1046-51
pubmed: 16381191
Atherosclerosis. 2015 Jul;241(1):100-10
pubmed: 25969893
Neurosurg Focus. 2019 Jul 1;47(1):E8
pubmed: 31261131
J Neurointerv Surg. 2013 Jul;5(4):327-31
pubmed: 22700728
Blood. 2005 Dec 1;106(12):3691-8
pubmed: 16105973
Neurol Med Chir (Tokyo). 2006 Jul;46(7):328-32; discussion 332
pubmed: 16861825
J Neurosurg. 2019 Aug 16;:1-11
pubmed: 31419795
J Neurointerv Surg. 2018 Jul;10(Suppl 1):i58-i67
pubmed: 30037960
Acta Neurochir Suppl. 2015;120:13-5
pubmed: 25366592
Hypertension. 2014 Jun;63(6):1339-44
pubmed: 24732889
Neurosurg Focus. 2019 Jul 1;47(1):E21
pubmed: 31261126
Stroke. 2009 Mar;40(3):942-51
pubmed: 19164781
Sci Signal. 2017 Feb 07;10(465):
pubmed: 28174280
Brain Sci. 2020 Feb 27;10(3):
pubmed: 32120907
Ann Intern Med. 1994 Aug 1;121(3):168-73
pubmed: 8017743
Acta Neurochir Suppl. 2020;127:35-41
pubmed: 31407060
Trends Pharmacol Sci. 2012 Jun;33(6):304-11
pubmed: 22464140
Br J Pharmacol. 2011 Jul;163(6):1237-49
pubmed: 21426319
J Neurosurg. 2014 May;120(5):1193-200
pubmed: 24628611
Lancet. 2017 Feb 11;389(10069):655-666
pubmed: 27637674
Stroke. 2011 Jan;42(1):173-8
pubmed: 21106959
Neurol Med Chir (Tokyo). 2019 Apr 15;59(4):126-132
pubmed: 30867357
Circulation. 2007 Dec 11;116(24):2830-40
pubmed: 18025535
Stroke. 2001 Mar;32(3):606-12
pubmed: 11239175
Stroke. 2006 Mar;37(3):900-5
pubmed: 16439700
Stroke. 2003 Dec;34(12):2781-7
pubmed: 14657543
Eur J Clin Invest. 2018 Sep;48(9):e12992
pubmed: 29962043
J Neurosurg. 2018 Apr 6;130(2):573-578
pubmed: 29624149
J Neurosurg. 2005 Dec;103(6):1052-7
pubmed: 16381192
N Engl J Med. 2017 Jul 20;377(3):257-266
pubmed: 28723321
J Neuroinflammation. 2014 Apr 16;11:77
pubmed: 24739142

Auteurs

Mieko Oka (M)

Department of Molecular Pharmacology, Research Institute, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Core Research for Evolutional Science and Technology (CREST) from Japan Agency for Medical Research and Development (AMED), National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Department of Neurosurgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.

Isao Ono (I)

Department of Molecular Pharmacology, Research Institute, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Core Research for Evolutional Science and Technology (CREST) from Japan Agency for Medical Research and Development (AMED), National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Department of Neurosurgery, Kyoto University Graduate School of Medicine, Tokyo 606-8507, Japan.

Kampei Shimizu (K)

Department of Molecular Pharmacology, Research Institute, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Core Research for Evolutional Science and Technology (CREST) from Japan Agency for Medical Research and Development (AMED), National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Department of Neurosurgery, Kyoto University Graduate School of Medicine, Tokyo 606-8507, Japan.

Mika Kushamae (M)

Department of Molecular Pharmacology, Research Institute, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Core Research for Evolutional Science and Technology (CREST) from Japan Agency for Medical Research and Development (AMED), National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Department of Neurosurgery, Showa University, Tokyo 142-8666, Japan.

Haruka Miyata (H)

Department of Molecular Pharmacology, Research Institute, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Core Research for Evolutional Science and Technology (CREST) from Japan Agency for Medical Research and Development (AMED), National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Department of Neurosurgery, Shiga University of Medical Science, Shiga 520-2192, Japan.

Takakazu Kawamata (T)

Department of Neurosurgery, Tokyo Women's Medical University, Tokyo 162-8666, Japan.

Tomohiro Aoki (T)

Department of Molecular Pharmacology, Research Institute, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Core Research for Evolutional Science and Technology (CREST) from Japan Agency for Medical Research and Development (AMED), National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.

Classifications MeSH